Jonathan Celli to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Jonathan Celli has written about Drug Resistance, Neoplasm.
Connection Strength
1.895
-
Liu Y, Mensah SK, Farias S, Khan S, Hasan T, Celli JP. Efficacy of photodynamic therapy using 5-aminolevulinic acid-induced photosensitization is enhanced in pancreatic cancer cells with acquired drug resistance. Photodiagnosis Photodyn Ther. 2024 Dec; 50:104362.
Score: 0.778
-
Struth E, Labaf M, Karimnia V, Liu Y, Cramer G, Dahl JB, Slack FJ, Zarringhalam K, Celli JP. Drug resistant pancreatic cancer cells exhibit altered biophysical interactions with stromal fibroblasts in imaging studies of 3D co-culture models. Sci Rep. 2024 09 05; 14(1):20698.
Score: 0.772
-
Kumar N, Cramer GM, Dahaj SAZ, Sundaram B, Celli JP, Kulkarni RV. Stochastic modeling of phenotypic switching and chemoresistance in cancer cell populations. Sci Rep. 2019 07 26; 9(1):10845.
Score: 0.135
-
Cramer GM, Jones DP, El-Hamidi H, Celli JP. ECM Composition and Rheology Regulate Growth, Motility, and Response to Photodynamic Therapy in 3D Models of Pancreatic Ductal Adenocarcinoma. Mol Cancer Res. 2017 01; 15(1):15-25.
Score: 0.111
-
Celli JP, Solban N, Liang A, Pereira SP, Hasan T. Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Lasers Surg Med. 2011 Sep; 43(7):565-74.
Score: 0.078
-
Evans CL, Abu-Yousif AO, Park YJ, Klein OJ, Celli JP, Rizvi I, Zheng X, Hasan T. Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT. PLoS One. 2011; 6(8):e23434.
Score: 0.020